Annual Working Capital
$13.22 M
-$67.59 M-83.64%
31 December 2023
Summary:
Zevra Therapeutics annual working capital is currently $13.22 million, with the most recent change of -$67.59 million (-83.64%) on 31 December 2023. During the last 3 years, it has risen by +$12.37 million (+1462.41%). ZVRA annual working capital is now -88.07% below its all-time high of $110.83 million, reached on 31 December 2021.ZVRA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$64.96 M
+$34.52 M+113.39%
30 September 2024
Summary:
Zevra Therapeutics quarterly working capital is currently $64.96 million, with the most recent change of +$34.52 million (+113.39%) on 30 September 2024. Over the past year, it has dropped by -$50.34 million (-43.66%). ZVRA quarterly working capital is now -50.39% below its all-time high of $130.93 million, reached on 01 September 2021.ZVRA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZVRA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.6% | -43.7% |
| 3 y3 years | +1462.4% | -50.4% |
| 5 y5 years | +12.8% | +3865.9% |
ZVRA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -88.1% | +1462.4% | -50.4% | +391.5% |
| 5 y | 5 years | -88.1% | +1462.4% | -50.4% | +192.7% |
| alltime | all time | -88.1% | +512.6% | -50.4% | +192.7% |
Zevra Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $64.96 M(+113.4%) |
| June 2024 | - | $30.44 M(-7.7%) |
| Mar 2024 | - | $32.98 M(+149.5%) |
| Dec 2023 | $13.22 M(-83.6%) | $13.22 M(-88.5%) |
| Sept 2023 | - | $115.30 M(+35.4%) |
| June 2023 | - | $85.17 M(-3.9%) |
| Mar 2023 | - | $88.66 M(+9.7%) |
| Dec 2022 | $80.81 M(-27.1%) | $80.81 M(+5.4%) |
| Sept 2022 | - | $76.70 M(-4.5%) |
| June 2022 | - | $80.28 M(-21.9%) |
| Mar 2022 | - | $102.83 M(-7.2%) |
| Dec 2021 | $110.83 M(>+9900.0%) | - |
| Dec 2021 | - | $110.83 M(-15.4%) |
| Sept 2021 | - | $130.93 M(+0.5%) |
| June 2021 | - | $130.22 M(+56.0%) |
| Mar 2021 | - | $83.49 M(+9768.9%) |
| Dec 2020 | $846.00 K(-45.1%) | $846.00 K(-101.4%) |
| Sept 2020 | - | -$62.65 M(-1.3%) |
| June 2020 | - | -$63.48 M(-9.4%) |
| Mar 2020 | - | -$70.05 M(-4645.6%) |
| Dec 2019 | $1.54 M | $1.54 M(-189.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$1.73 M(-72.8%) |
| June 2019 | - | -$6.33 M(-4657.6%) |
| Mar 2019 | - | $139.00 K(-98.8%) |
| Dec 2018 | $11.72 M(-65.9%) | $11.72 M(-838.8%) |
| Sept 2018 | - | -$1.59 M(-111.9%) |
| June 2018 | - | $13.31 M(-47.3%) |
| Mar 2018 | - | $25.27 M(-26.5%) |
| Dec 2017 | $34.39 M(-49.2%) | $34.39 M(-21.0%) |
| Sept 2017 | - | $43.55 M(-10.7%) |
| June 2017 | - | $48.77 M(-16.2%) |
| Mar 2017 | - | $58.21 M(-14.0%) |
| Dec 2016 | $67.72 M(+48.1%) | $67.72 M(+13.7%) |
| Sept 2016 | - | $59.56 M(-22.8%) |
| June 2016 | - | $77.18 M(-26.9%) |
| Mar 2016 | - | $105.54 M(+130.8%) |
| Dec 2015 | $45.74 M(+621.0%) | $45.74 M(-13.4%) |
| Sept 2015 | - | $52.82 M(-11.8%) |
| June 2015 | - | $59.92 M(+852.6%) |
| Mar 2015 | - | $6.29 M(-0.8%) |
| Dec 2014 | $6.34 M(-298.0%) | $6.34 M |
| Dec 2013 | -$3.20 M | - |
FAQ
- What is Zevra Therapeutics annual working capital?
- What is the all time high annual working capital for Zevra Therapeutics?
- What is Zevra Therapeutics annual working capital year-on-year change?
- What is Zevra Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly working capital year-on-year change?
What is Zevra Therapeutics annual working capital?
The current annual working capital of ZVRA is $13.22 M
What is the all time high annual working capital for Zevra Therapeutics?
Zevra Therapeutics all-time high annual working capital is $110.83 M
What is Zevra Therapeutics annual working capital year-on-year change?
Over the past year, ZVRA annual working capital has changed by -$67.59 M (-83.64%)
What is Zevra Therapeutics quarterly working capital?
The current quarterly working capital of ZVRA is $64.96 M
What is the all time high quarterly working capital for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly working capital is $130.93 M
What is Zevra Therapeutics quarterly working capital year-on-year change?
Over the past year, ZVRA quarterly working capital has changed by -$50.34 M (-43.66%)